LOXL2 and neoplasm: In the nucleus, LOXL2 binds specifically to the short isoform of BRD4 (BRD4S) (Fig 2B) that in TNBC has been recently describe as oncogenic, but not to the long one (BRD4L), which has a tumor suppressive role (Wu et al, 2020).